Hyewon Ryu
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- Chemokine receptors and signaling
Papers in
- Co-authors
- Hyo Jin Lee (30 shared papers)Ik‐Chan Song (26 shared papers)Il Hwan Kim (7 shared papers)Changhoon Yoo (8 shared papers)Jaekyung Cheon (7 shared papers)Baek‐Yeol Ryoo (6 shared papers)Jae Ho Jeong (5 shared papers)Kyu‐pyo Kim (7 shared papers)
- Journals
- Medicine (6 papers)Cancer Research and Treatment (5 papers)Annals of Oncology (3 papers)International Journal of Medical Sciences (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Hyewon Ryu
54 papers receiving 663 citations
Hyewon Ryu's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 175
- Internal Medicine 18
- Genetics 49
- Surgery 192
- Pulmonary and Respiratory Medicine 104
Countries citing papers authored by Hyewon Ryu
This map shows the geographic impact of Hyewon Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyewon Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyewon Ryu more than expected).
Fields of papers citing papers by Hyewon Ryu
This network shows the impact of papers produced by Hyewon Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyewon Ryu. The network helps show where Hyewon Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hyewon Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study Hit paper breakdown → | 2021 | 145 |
| 2 | 2023 | 51 | |
| 3 | 2018 | 28 | |
| 4 | 2021 | 24 | |
| 5 | Decursin inhibits cell growth and autophagic flux in gastric cancer via suppression of cathepsin C. | 2021 | 22 |
| 6 | 2019 | 22 | |
| 7 | 2015 | 21 | |
| 8 | Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression. | 2019 | 21 |
| 9 | 2020 | 20 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 19 | |
| 12 | 2017 | 19 | |
| 13 | 2022 | 18 | |
| 14 | 2017 | 18 | |
| 15 | 2017 | 17 | |
| 16 | 2018 | 17 | |
| 17 | 2020 | 17 | |
| 18 | 2022 | 15 | |
| 19 | 2017 | 13 | |
| 20 | 2021 | 12 |
About Hyewon Ryu
Hyewon Ryu is a scholar working on Oncology, Genetics, Hematology, Surgery and Rheumatology, having authored 58 papers that have together received 673 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Chemokine receptors and signaling (6 papers), Palliative Care and End-of-Life Issues (6 papers), Eosinophilic Disorders and Syndromes (5 papers), Ovarian cancer diagnosis and treatment (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Oncology (175 citations), Internal Medicine (18 citations), Genetics (49 citations), Surgery (192 citations) and Pulmonary and Respiratory Medicine (104 citations). Hyewon Ryu has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Hyo Jin Lee, Ik‐Chan Song, Il Hwan Kim, Changhoon Yoo, Jaekyung Cheon, Baek‐Yeol Ryoo, Jae Ho Jeong, Kyu‐pyo Kim, Myoung Joo Kang and Ji Sung Lee. Their work appears in journals such as Medicine, Cancer Research and Treatment, Annals of Oncology, International Journal of Medical Sciences and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.